Breaking News

Argentina Didn't Reach an Agreement With Holdouts: Mediator

Patheon Completes Plan of Arrangement

                    Patheon Completes Plan of Arrangement  PR Newswire  TORONTO, March 11, 2014  TORONTO, March 11, 2014 /PRNewswire/ - Patheon Inc. (TSX: PTI) ("Patheon") announced today the completion of the previously announced statutory plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act, pursuant to the arrangement agreement between Patheon and JLL/Delta Patheon Holdings, L.P. ("DPx") dated November 18, 2013. DPx is sponsored by an entity controlled by an affiliate of JLL Partners, Inc. ("JLL") and Koninklijke DSM N.V. ("DSM").  Pursuant to the  Arrangement, DPx indirectly  acquired all of  the issued  and  outstanding restricted voting shares of Patheon at a price of US$9.32 cash for each share. All of the outstanding options of Patheon were deemed to be vested and holders are entitled to receive a cash amount equal to the amount by which US$9.32 exceeds  the  exercise price  of  such  option. All  options  with  an  exercise price  equal  to  or  greater than  US$9.32  were  cancelled  without  consideration. All payments are subject  to applicable withtholding taxes,  if  any.  For registered holders of Patheon's  restricted voting shares, payment of  the  consideration will be processed after holders deposit their share certificates with Computershare Trust Company of  Canada (the "Depositary"), in  accordance  with the  instructions  in  the  Letter  of  Transmittal  previously  sent  to  registered shareholders. Any questions regarding payment of the consideration, including any request  for another form  of Letter of  Transmittal, should  be  directed to the  Depositary via telephone  at 1 (800)  564-6253 (toll free  in  North   America)   or   via   email   at  Non-registered shareholders will receive payment of the consideration  through  their broker, investment  dealer, bank,  trust company  or other  intermediary  that holds  the  restricted  voting shares  on  their  behalf.  Non-registered  shareholders should contact  their broker  or other  intermediary for  further  details.  Patheon has  withdrawn its  shares from  registration with  the United  States  Securities and Exchange Commission. Delisting of the restricted voting  shares  from the  Toronto Stock  Exchange is  expected to  occur shortly.  As soon  as  practicable after the delisting of its restricted voting shares, Patheon  will  apply to all applicable Canadian securities regulatory authorities to cease to be a reporting issuer.  Pursuant to the  Arrangement, Patheon  was amalgamated  with JLL/Delta  Canada  Inc., an indirect subsidiary  of DPx, and will  continue to carry on  business  under the name "Patheon Inc."  In connection with the completion of the Arrangement, DSM's DSM Pharmaceutical Products ("DPP") business group was combined with Patheon.  Further details with  respect to  the Arrangement  can be  found in  Patheon's  proxy statement and management information circular dated February 4, 2014.  About Patheon Inc.  Patheon  a leading  provider of  contract development  and  commercial  manufacturing services to the global pharmaceutical industry for a full  array  of solid and sterile  dosage forms. Through  the company's recent  acquisition  ofBanner Pharmacaps-  a market  leader in  soft gelatin  capsule  technology  -Patheonnow also includes a proprietary products and technology business.  Patheonprovides the highest  quality products and  services to  approximately  300 of the  world's leading  pharmaceutical and  biotechnology companies.  The  company's integrated network consists of 15 locations, including 12 commercial contract manufacturing  facilities  and  9  development  centers  acrossNorth  AmericaandEurope.Patheonenables customer  products  to  be  launched  with  confidence anywhere in the world. For more information  This press  release  is  issued  in  compliance  with  section  102.1  of  the  Securities Act  (Ontario) and  National Instrument  62-103 The  Early  Warning  System and Related Take-Over  Bid and Insider  Reporting Issues in  connection  with the  acquisition  by JLL/Delta  Canada  Inc., an  indirect  wholly  owned  subsidiary of DPx, of all of the restricted voting shares of Patheon  pursuant  to the Arrangement. A press release and early warning report in respect of the acquisition of all of the restricted voting shares of Patheon pursuant to  the  Arrangement will  be  filed  with  the  applicable  securities  commission  or  securities regulator in each jurisdiction in which the Patheon is a  reporting  issuer.                              JLL/Delta Canada Inc.                               2100 Syntex Court                          Mississauga, Ontario, Canada                                    L5N 7K9  To obtain a copy of the  early warning report, please contact Daniel  Agroskin  at 212-286-8600.  Cautionary Statement  No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.  SOURCE Patheon Inc.  Contact:  Contact: Patheon Inc. Tel: (919) 226-3200